Kazuko Matsuda, M.D., Ph.D., MPH

Kazuko Matsuda, M.D., Ph.D., MPH

Senior Vice President, Chief Medical OfficeratMedicinova· In proxies 2023–2025

Pay in FY2025+33% from the year before · Medicinova stock -37.6% the same year

Kazuko Matsuda, M.D., Ph.D., MPH was paid $1.3M in FY2025 (Dec), up 33%. Medicinova stock fell 37.6% that year.

Pay$100 in the stock at the end of FY22 → $64
Pay is from the Summary Compensation Table of each Medicinova proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. MedicinovaPublic company · 3 yr
    • Senior Vice President, Chief Medical Officer2023 – Present · 3 yrStock in role -27%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?